.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
McKinsey
Queensland Health
Daiichi Sankyo
US Department of Justice
Novartis
Moodys
Cipla
Farmers Insurance
QuintilesIMS

Generated: February 21, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: propafenone hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Glenmark Pharms LtdPROPAFENONE HYDROCHLORIDEpropafenone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205268ANDAGlenmark Pharmaceuticals Inc., USAN68462-408-60
Glenmark Pharms LtdPROPAFENONE HYDROCHLORIDEpropafenone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205268ANDAGlenmark Pharmaceuticals Inc., USAN68462-409-60
Glenmark Pharms LtdPROPAFENONE HYDROCHLORIDEpropafenone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205268ANDAGlenmark Pharmaceuticals Inc., USAN68462-410-60
Mylan Pharms IncPROPAFENONE HYDROCHLORIDEpropafenone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL203803ANDAMylan Pharmaceuticals Inc.N0378-1258-91
Mylan Pharms IncPROPAFENONE HYDROCHLORIDEpropafenone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL203803ANDAMylan Pharmaceuticals Inc.N0378-1258-05
Mylan Pharms IncPROPAFENONE HYDROCHLORIDEpropafenone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL203803ANDAMylan Pharmaceuticals Inc.N0378-1259-05
Mylan Pharms IncPROPAFENONE HYDROCHLORIDEpropafenone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL203803ANDAMylan Pharmaceuticals Inc.N0378-1259-91
Mylan Pharms IncPROPAFENONE HYDROCHLORIDEpropafenone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL203803ANDAMylan Pharmaceuticals Inc.N0378-1261-05
Mylan Pharms IncPROPAFENONE HYDROCHLORIDEpropafenone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL203803ANDAMylan Pharmaceuticals Inc.N0378-1261-91
Par PharmPROPAFENONE HYDROCHLORIDEpropafenone hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL078540ANDARebel Distributors CorpE21695-814-60
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Fuji
Cantor Fitzgerald
Chinese Patent Office
Moodys
US Department of Justice
Queensland Health
Boehringer Ingelheim
Julphar

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot